ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Ciba Specialty Chemicals and Australia's Biosignal will develop antimicrobial products based on Biosignal's antibiofilm technology. Ciba will have an exclusive license to the technology in markets including plastics, coatings, paints, fibers, and paper products. The formation of biofilms in many industrial environments can lead to fouling, corrosion, and material degradation. Biosignal's technology is based on a discovery that the Eastern Australian seaweed Delisea pulchra produces natural furanones that disable bacterial ability to colonize.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter